Stockscreener 앱 받기
1.17
1.74%
0.02
시간 외 거래:
1.12
-0.05
-4.27%
전일 마감가:
$1.15
열려 있는:
$1.12
하루 거래량:
565.33K
Relative Volume:
1.60
시가총액:
$74.56M
수익:
-
순이익/손실:
$-64.20M
주가수익비율:
-0.5442
EPS:
-2.15
순현금흐름:
$57,000
1주 성능:
-8.59%
1개월 성능:
-15.22%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.09
$1.20
1주일 범위
$1.09
$1.31
52주 변동 폭
$1.09
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
명칭
Climb Bio Inc
전화
1-866-857-2596
주소
20 WILLIAM STREET, WELLESLEY HILLS
CLYM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.17 | 74.56M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
Climb Bio Inc 주식(CLYM)의 최신 뉴스
CLYM stock touches 52-week low at $1.2 amid market challenges - Investing.com Australia
Climb Bio expands board with two new directors By Investing.com - Investing.com Australia
Climb Bio appoints Kim Cobleigh Drapkin, Bo Cumbo to board - TipRanks
Climb Bio expands board with two new directors - Investing.com
Climb Bio Expands Board with New Director Appointments - TipRanks
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study - The Manila Times
Biotech Leaders Join Climb Bio Board: 11 Successful Drug Launches Experience - Stock Titan
CLYM stock touches 52-week low at $1.2 amid market challenges By Investing.com - Investing.com South Africa
What is Leerink Partnrs’ Estimate for Climb Bio Q2 Earnings? - Defense World
Bioplastics And Biopolymers Market Key Drivers, Opportunities and Trends | Exactitude Consultancy - Yahoo Finance
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Healthcare Spotlight: Climb Bio Takes Center Stage at Major Needham Conference - Stock Titan
Climb Bio Advances Clinical Trials and Expands Pipeline - TipRanks
Can you use home equity to pay for long-term care? - Yahoo Finance
Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Quarterly Update Report - Yahoo Finance
Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Downloadable Quarterly Update - Yahoo Finance
Citigroup (C) Could Be a Great Choice - Yahoo Finance
China deals look beyond cancer - BioCentury
Climb Bio Files For Offering Of Common Stock Up To $22.4 MillionSEC Filing - MarketScreener
Climb Bio Reports Fourth Quarter And Year-End 2024 Financial Results And Provides Business Updates - Marketscreener.com
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates - Yahoo
Conagra to close Michigan plant, impacting 85 jobs - Yahoo Finance
Exclusive: BlackRock expands blockchain-based money market to Solana, in tie-up with startup Securitize - Yahoo Finance
Climb Bio Secures 3-Year Cash Runway with $212M, Advances Multi-Disease Pipeline - Stock Titan
Climb bio SVP Emily Pimblett sells shares worth $1,570 By Investing.com - Investing.com South Africa
Climb bio SVP Emily Pimblett sells shares worth $1,570 - Investing.com India
Why Are Jabil (JBL) Shares Soaring Today - Yahoo Finance
Climb Bio: Meet The Newest Star in Autoimmune Disease Treatment – Initiation Report - Yahoo Finance
Climb Bio (CLYM) Expected to Announce Earnings on Thursday - Defense World
Gossamer Bio shares rise on Q4 earnings beat By Investing.com - Investing.com South Africa
Gossamer Bio shares rise on Q4 earnings beat - Investing.com India
Bio-Key International Inc (BKYI): Major Improvements, Worth A Look - Stocks Register
Sugar Prices Climb on the Prospects for Lower Global Sugar Production - The Globe and Mail
Sugar Prices Climb on the Outlook for Small Sugar Output in India - The Globe and Mail
CLYM stock touches 52-week low at $1.29 amid market challenges - Investing.com Australia
CLYM stock touches 52-week low at $1.29 amid market challenges By Investing.com - Investing.com South Africa
(PDF) Research on Dynamics and Stability in the Stairs-Climbing of a Tracked Mobile Robot - ResearchGate
Stocks of Codexis Inc (CDXS) are poised to climb above their peers - SETE News
Mineralys shares climb on study data for blood pressure drug - BioPharma Dive
First-class stamp price climbs to £1.70 in ‘blow to consumers’ - Yahoo Finance UK
Global stocks climb as pound and euro hit four-month high against US dollar - Yahoo Finance UK
Climb Bio (NASDAQ:CLYM) Shares Down 6.9% – Should You Sell? - Defense World
FTSE 100 and US stocks climb higher as US inflation report meets expectations - Yahoo Finance UK
Stocks Climb Ahead Of Nvidia's Earnings Results - Barchart
Coupang’s shares climb after profit surges in competitive market - Fortune
CLYM stock touches 52-week low at $1.4 amid market challenges - Investing.com Australia
CLYM stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa
Plug To Announce 2024 Fourth Quarter and Year-End Results - The Manila Times
Climb Bio to Present at Upcoming Investor Conferences - The Bakersfield Californian
Climb Bio Sets Investor Calendar: Key March Presentations at Major Healthcare Conferences - StockTitan
Climb Bio Inc (CLYM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Climb Bio Inc 주식 (CLYM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Sep 20 '24 |
Sale |
8.18 |
1,191 |
9,741 |
7,564 |
| Morisset Valerie | EVP, R&D AND CSO |
Jul 22 '24 |
Sale |
8.03 |
69,005 |
554,170 |
31,317 |
| Morisset Valerie | EVP, R&D AND CSO |
Jul 19 '24 |
Sale |
7.21 |
60,201 |
434,325 |
100,322 |
| Morisset Valerie | EVP, R&D AND CSO |
Jul 18 '24 |
Sale |
6.93 |
38,576 |
267,332 |
160,523 |
| Morisset Valerie | EVP, R&D AND CSO |
Jul 17 '24 |
Sale |
6.91 |
3,207 |
22,160 |
199,099 |
| Morisset Valerie | EVP, R&D AND CSO |
Jul 16 '24 |
Sale |
7.13 |
50,000 |
356,500 |
202,306 |
| Morisset Valerie | EVP, R&D AND CSO |
Jul 12 '24 |
Sale |
7.07 |
50,000 |
353,500 |
294,683 |
| Morisset Valerie | EVP, R&D AND CSO |
Jul 15 '24 |
Sale |
7.01 |
42,377 |
297,063 |
252,306 |
| Morisset Valerie | EVP, R&D AND CSO |
Jul 11 '24 |
Sale |
7.11 |
50,000 |
355,500 |
344,683 |
10.70%
자본화:
|
볼륨(24시간):